AI-generated summary
The authors report an interim analysis of 33 patients with chronic wounds treated with a light-emitting BioPhotonic gel in an uncontrolled, open-label, real-life study. They found that 52% of patients achieved total wound closure, and that no related serious adverse events were observed. The study had no control group and was based on an early interim subset of the planned enrollment.
- Participants
- 33
- Who or what was studied
- Adults with chronic wounds (venous leg ulcers, diabetic foot ulcers, and pressure ulcers) treated at seven wound centers in Italy.
- Limits stated in the abstract
- The study was uncontrolled and open-label, and the results come from an early interim analysis of only the first 33 subjects who completed the study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wound healing, Open-label study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.